-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
HSC_colony_many_years_post_allogeneic_bone_marrow_transplant___Bait_set_2
Study
EGAS00001005534
-
Oncogenic cooperation in a human de novo T-ALL model
Study
EGAS00001006055
-
Molecular and functional profiling of plasmablastic lymphoma
Study
EGAS00001004659
-
Enhanced cortical neural stem cell identity through SMAD/WNT inhibition in human cerebral organoids facilitates emergence of outer radial glial cells
Study
EGAS00001006063
-
A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
Study
EGAS00001004704
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
single cell RNA-seq and ATAC-seq of human fetal forebrain tissue
Study
EGAS00001006136
-
Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements
Study
EGAS00001003415
-
Comprehensive genomic and transcriptomic analysis of three synchronous primary tumours and a recurrence from a head and neck cancer patient
Study
EGAS00001004857
-
Genomic analysis of a hypermutated gliosarcoma
Study
EGAS00001004864
-
The effect of pre-analytical and physiological variables on cell-free DNA fragmentation
Study
EGAS00001005748
-
The European MAPPYACTS trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
Study
EGAS00001005935
-
Exome sequencing of synchronous colorectal cancers
Study
EGAS00001003474
-
RNA-seq on patient-derived, stage II, CRC cell lines
Study
EGAS00001005948
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
Combined gene expression and digital pathology identifies molecular mediators of T cell exclusion and immune suppression in ovarian cancer
Study
EGAS00001003487
-
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs drug target discovery in ankylosing spondylitis
Study
EGAS00001006233
-
Human genome-wide variations in the Massim region
Study
EGAS00001006010
-
Loss of Epigenetic Barrier is Required for Enhancer Hijacking-Mediated Oncogenic Transcription
Study
EGAS00001006140
-
MutWP5__CRUK_Mutographs_of_Cancer__BRCA_Carriers___WG__Novaseq_
Study
EGAS00001003523
-
Phase 1 CX-5461 Trial (Canadian Cancer Trials Group Trial IND.231)
Study
EGAS00001006173